# Living Donor Wage Reimbursement Trial

> **NIH NIH R01** · BETH ISRAEL DEACONESS MEDICAL CENTER · 2020 · $257,068

## Abstract

PROJECT SUMMARY / ABSTRACT
The waiting list for kidney transplantation (KT) now exceeds 100,000 and waiting times exceed 7 yrs in some
U.S. regions. Live donor kidney transplantation (LDKT) accelerates the path to transplantation and yields
superior outcomes compared to dialysis and deceased donor KT. However, the annual number of LDKTs has
declined over the last decade, particularly among minority and low-income patients. We hypothesize, and have
preliminary data to support, that the financial impact on living donors (LDs) is a major contributor to the LDKT
decline and for persistent racial disparities in LDKT rates. Many LDs have substantial non-reimbursed direct
and indirect costs, most notably the loss of income or wages following surgery. In this study, we will: (1)
evaluate the effectiveness of offering reimbursement for LD lost wages on the LDKT rate; (2) examine whether
offering reimbursement for LD lost wages reduces known racial disparities in LDKT; and (3) determine whether
study outcomes differ significantly by maximum reimbursement amount for LD lost wages. To accomplish
these aims, we will conduct a blended randomized trial and matched historical control study with a planned
enrollment of 350 KT candidates who will be randomized to one of two parallel arms: (1) possible
reimbursement of LD lost wages up to $1,500 (LW-1.5), or (2) possible reimbursement of LD lost wages up to
$3,000 (LW-3.0). Our central hypotheses are that offering reimbursement for LD lost wages will (a) yield higher
LDKT rates overall relative to matched historical controls, and (b) reduce the disparity between LDKT rates in
white and minority patients relative to historical patterns. Also, we hypothesize that KT candidates who are
offered up to $3,000 reimbursement for LD lost wages will have a higher likelihood of LDKT compared to those
offered up to $1,500 of reimbursement for LD lost wages. Finally, we will assess the impact of offering
reimbursement for LD lost wages on the decision-making of both KT candidates and potential LDs as well as
perceptions of pressure/coercion and decision stability. Overall, the proposed study will be the first to
empirically examine the impact of offering LD lost wages reimbursement on the willingness of KT candidates to
pursue LDKT, racial disparity in LDKT, rates of LD evaluations, and actual LDKT rates. Moreover, this study
will be the first to examine the differential impact on these outcomes of offering to reimburse LD lost wages for
different amounts ($1,500 vs. $3,000) after donation. As such, findings from this study have very high potential
to impact policy, clinical practice, LDKT access, and known income and racial disparities in KT. The assembled
interdisciplinary research team has a long track record of collaboration and is internationally recognized for
developing innovative strategies to increase LDKT access in disadvantaged patient populations, extramural
funding to conduct large RCTs and multi-center studies, an...

## Key facts

- **NIH application ID:** 9980402
- **Project number:** 5R01DK114877-04
- **Recipient organization:** BETH ISRAEL DEACONESS MEDICAL CENTER
- **Principal Investigator:** James R Rodrigue
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $257,068
- **Award type:** 5
- **Project period:** 2017-08-01 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9980402

## Citation

> US National Institutes of Health, RePORTER application 9980402, Living Donor Wage Reimbursement Trial (5R01DK114877-04). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9980402. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*